chartexchange

RAIN
Rain Enhancement Technologies Holdco, Inc. Class A Common Stock
stockNASDAQ

Market OpenNov 13, 2026 11:22:19 AM EST
0.65USD+37.281%(+0.18)89,689,239
Pre-marketNov 13, 2026 9:29:30 AM EST
0.5275USD+11.357%(+0.0538)
0.4700Bid0.6200Ask0.1500Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Newark, CA, USA
Previous Close
$0.46
Beta
1.33
52-Week High
$8.52 2025-12-22
52-Week Low
$0.46 2026-11-12
SMA 50
$0.69
SMA 200
$1.72
Avg. Vol 10D
780,906
Avg. Vol 30D
317,877
Avg. Vol 90D
1.31M
Relative Vol
154.08
2.01M
114.6000%
100
RAIN Profile

rain therapeutics is a san francisco bay area-based biotechnology company, focused on developing small molecule targeted therapeutics for cancer patients that possess a clear, and single, oncogenic driver.

RAIN Performance
PeriodPriceDateChangeBeta
1W0.502026-11-06+29.98%6.801
1M0.652026-10-13+0.57%2.241
3M0.972026-08-13-32.60%2.020
6M1.512026-05-13-56.70%1.749
1Y5.572025-11-13-88.26%1.328
2Y7.302025-01-02-91.04%—
5Y16.092021-11-12-95.94%0.740
RAIN Stock Summary

Rain Enhancement Technologies Holdco, Inc. Class A Common Stock (NASDAQ:RAIN) stock price today is $0.65, and today's volume is 48,978,494. RAIN is up 38.020% today. The 30 day average volume is 317,877. RAIN market cap is $7.65M with 11.70M shares outstanding.